Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Hycamtin – Anti-Tumour Drug for Treatment of Relapsed Small Cell Lung Cancer

Drug (Brand / Generic)

Hycamtin / topotecan hydrochloride

Company / Licensee

GlaxoSmithKline

Therapy Class

Topoisomerase I- inhibitor

Product Description

Anti-tumour drug, damages the genetic material of the cell

Current Indication

Small cell lung cancer

Market Sector

Oncology

Development Status

Approved by FDA
Expand

Go Top